Marker Therapeutics, Inc. Earnings Per Share Diluted

• Marker Therapeutics, Inc. showed an increase of +33.6% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Marker Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2015 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2015 to 2025), Marker Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 91.5%.
• Historical annual values: Fiscal year 2025: $0.79 (loss) per share | Fiscal year 2024: $1.19 (loss) per share | Fiscal year 2023: $0.94 (loss) per share | Fiscal year 2022: $3.58 (loss) per share | Fiscal year 2021: $5.47 (loss) per share | Fiscal year 2020: $0.61 (loss) per share | Fiscal year 2017: $1.16 (loss) per share | Fiscal year 2016: $0.72 (loss) per share | Fiscal year 2015: $9.30 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026